Academic Bibliography

Mark

Effect of early and systematic integration of palliative care in patients with advanced cancer : a randomised controlled trial

Gaëlle Vanbutsele (UGent) , Koen Pardon (UGent) , Simon Van Belle (UGent) , Veerle Surmont (UGent) , Martine De Laat (UGent) , Roos Colman (UGent) , Kim Eecloo (UGent) , Veronique Cocquyt (UGent) , Karen Geboes (UGent) and Luc Deliens (UGent)

(2018) LANCET ONCOLOGY. 19(3). p.394-404

Mark

Effect of early palliative care : complex intervention and complex results : authors' reply

Gaëlle Vanbutsele (UGent) , Koen Pardon (UGent) , Simon Van Belle (UGent) , Veerle Surmont (UGent) , Martine De Laat (UGent) , Roos Colman (UGent) , Kim Eecloo (UGent) , Veronique Cocquyt (UGent) , Karen Geboes (UGent) and Luc Deliens (UGent)

(2018) LANCET ONCOLOGY. 19(5). p.e222-e222

Mark

misc

A middle-aged woman with a heavy heart

Cedric Van de Bruaene, Lara Crapé and Veerle Surmont (UGent)

(2017) HEART. 103(13). p.1053-1053

Mark

journalArticle
A1
open access

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT) : an open-label, phase 3, randomised, superiority trial

Corinne Faivre-Finn, Michael Snee, Linda Ashcroft, Wiebke Appel, Fabrice Barlesi, Adityanarayan Bhatnagar, Andrea Bezjak, Felipe Cardenal, Pierre Fournel, Susan Harden, et al.

(2017) LANCET ONCOLOGY. 18(8). p.1116-1125

Mark

Addressing the palliative setting in advanced lung cancer should not remain a barrier : a multicenter study

Annelies Janssens, Sofie Derijcke, Anneke Lefebure, Elke Vandenbroucke, Veerle Surmont (UGent) , Dieter Coeman, Daniëlle Galdermans, Ann-Marie Morel, Birgitta I Hiddinga and Jan P van Meerbeeck

(2017) CLINICAL LUNG CANCER. 18(4). p.e283-e287

Mark

Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer : has it yet become state-of-the-art?

Lotte van der Weijst (UGent) , Veerle Surmont (UGent) , Wim Schrauwen (UGent) and Yolande Lievens (UGent)

(2017) CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 119. p.40-49

Mark

Adaptive radiotherapy for locally advanced non-small cell lung cancer : dosimetric gain and treatment outcome prediction

PATRICK BERKOVIC (UGent) , Leen Paelinck (UGent) , Akos Gulyban, Marc Van Eijkeren (UGent) , Veerle Surmont (UGent) , Yolande Lievens (UGent) and Katrien Vandecasteele (UGent)

(2017) ACTA ONCOLOGICA. 56(11). p.1656-1658

Mark

Pembrolizumab vs docetaxel for previously treated NSCLC (KEYNOTE-010) : archival vs new tumor samples for PD-L1 assessment

Roy S Herbst, Paul Baas, Jose L Perez-Gracia, Enriqueta Felip, Dong-Wan Kim, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn, et al.

(2016) JOURNAL OF THORACIC ONCOLOGY. 11(10, suppl.). p.S242-S243

Mark

Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: a single-arm phase II study (EORTC-08061)

Fatma Abdelraouf, Egbert Smit, Baktiar Hasan, Jessica Menis, Sanjay Popat, Jan Van Meerbeeck (UGent) , Veerle Surmont (UGent) , Paul Baas and Mary O'Brien

(2016) EUROPEAN JOURNAL OF CANCER. 54. p.35-39

Mark

Pembrolizumab vs docetaxel for previously treated NSCLC (KEYNOTE-010) : archival vs new tumor samples for PD-L1 assessment

Roy S Herbst, Paul Baas, Jose L Perez-Gracia, Enriqueta Felip, Dong-Wan Kim, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn, et al.

(2016) JOURNAL OF THORACIC ONCOLOGY. 11(10, suppl.). p.S174-S175

Academic Bibliography

Effect of early and systematic integration of palliative care in patients with advanced cancer : a randomised controlled trial

Effect of early palliative care : complex intervention and complex results : authors' reply

A middle-aged woman with a heavy heart

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT) : an open-label, phase 3, randomised, superiority trial

Addressing the palliative setting in advanced lung cancer should not remain a barrier : a multicenter study

Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer : has it yet become state-of-the-art?

Adaptive radiotherapy for locally advanced non-small cell lung cancer : dosimetric gain and treatment outcome prediction

Pembrolizumab vs docetaxel for previously treated NSCLC (KEYNOTE-010) : archival vs new tumor samples for PD-L1 assessment

Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: a single-arm phase II study (EORTC-08061)

Pembrolizumab vs docetaxel for previously treated NSCLC (KEYNOTE-010) : archival vs new tumor samples for PD-L1 assessment

Contents

Support

Contact